期刊文献+

薯蓣丸治疗围绝经期女性慢性荨麻疹的疗效观察 被引量:5

Efficacy Observation of Shuyu Pills in the Treatment of Chronic Urticaria in Perimenopausal Women
原文传递
导出
摘要 目的:观察薯蓣丸治疗围绝经期女性慢性荨麻疹的临床疗效与安全性。方法:将围绝经期女性慢性荨麻疹患者74例,随机分为治疗组(48例)和对照组(26例),观察2组总体疗效、远期疗效及不良反应。结果:治疗组和对照组总有效率分别为81.25%、57.69%,复发率分别为19.05%、45.45%,2组比较有显著性差异(P<0.05)。治疗期间治疗组未见不良反应,对照组有20例出现嗜睡、乏力等不适,停药后消失。结论:薯蓣丸治疗围绝经期女性慢性荨麻疹疗效好,复发率低,不良反应少。 OBJECTIVE: To observe the clinical efficacy of Shuyu pills in the treatment of chronic urticaria in perimenopausal women. METHODS: 74 perimenopausal women with chronic urticaria were randomly divided into treatment group (48 cases) and control group (26 cases). The total efficacy, long-term efficacy and adverse drug reactions were observed. RESULTS: The total effective rates were 81.25% for treatment group and 57.69% for control group. The relapse rates were 19.05% and 45.45%, respectively. Significant difference was found between 2 groups(P0.05). No adverse drug reaction was found in treatment group during treatment. In control group 20 cases suffered form somenolence and feeble, etc. The symptoms all disappeared after drug withdarwal. CONCLUSION: Shuyu pills for perimenopausal women with chronic urticaria have sound efficacy, low relapse rate and less adverse drug reactions.
出处 《中国药房》 CAS CSCD 北大核心 2011年第20期1893-1894,共2页 China Pharmacy
关键词 薯蓣丸 围绝经期女性 慢性荨麻疹 疗效 Shuyu pills Perimenopausal women Chronic urticaria Efficacy
  • 相关文献

参考文献8

二级参考文献27

  • 1[1]Greaves MW. Chronic urticaria[J]. N Engl J Med, 1995, 332(26):1767-1772.
  • 2[2]O' Donnell BF, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life[J] . Br J Dermatol, 1997, 136(2):197-201.
  • 3[3]Grattan CE, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria-a clinical , immunological and histological evaluation[J]. Br J Dermatol, 1986, 114(5): 583-590.
  • 4[4]Grattan CE, Francis DM, Hide M, et al. Detection of circulating histamine releasing autoantibodies with function properties of anti-IgE in chronic urticaria[J]. Clin Exp Allergy, 1991, 21 (6):695-704.
  • 5[5]Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause for histamine release in chronic urticaria[J]. N Engl J Med, 1993, 328(22): 1599-1604.
  • 6[6]Niimi N, Francis DM, Kermani F , et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria[J]. J Invest Dermatol, 1996, 106(5): 1001-1006.
  • 7[7]Tong LJ, Balakrishnan G, Kochan JP, et al. Assessment of autoimmunity in patients with chronic urticaria[J] . J Allergy Clin Immunol, 1997, 99(4): 461-465.
  • 8[8]Fiebiger E , Maurer D, Holub H, et al. Serum IgG autoantibodies directed against the alpha-chain of FcepsilonR: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria and pathogenetic factor for a distinct subset of chronic urticaria patients/[J]. J Clin Invest, 1995, 96(6): 2606-2612.
  • 9[9]Fiebiger E, Hammersehmid F, Stingl G, et al. Anti- FcepsilonR autoantibodies in autoimmune-mediated disorder. Identification of a structure-function relationship[J] . J Clin Invest, 1998, 101 (1):243-251.
  • 10[10]O' Donnell BF, O' Neill CM, Francis DM, et al. Human leucocyte antigen class Ⅱ associations in chronic idiopathic urticaria[J] . Br J Dermatol, 1999, 140(5): 853-858.

共引文献1536

同被引文献88

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部